Phreesia, Inc. Common Stock (PHR)

Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Other gainers include Snowflake, Genius Group, and Astrotech.

Phreesia (PHR) Q1 2027 Earnings Transcript

Phreesia (NYSE:PHR) reported higher first-quarter revenue and profitability for fiscal 2027, with executives pointing to growth in payment solutions, expanding opportunities from its AccessOne acquisition and continued investment in patient intake, provider engagement and artificial intelligence. O

An analyst downgraded his recommendation on the company.

Phreesia isn't frozen solid, but it does seem set to grow slower.

The digital healthcare landscape faced a harsh reality check on February 6, 2026, as shares of Doximity, Inc. (NYSE: DOCS) plummeted 17% in early trading. Despite reporting fiscal third-quarter results that surpassed analyst estimates for both revenue and earnings, the professional network for physicians issued a tepid outlook for the

The digital health landscape faced a sobering milestone this week as shares of Doximity, Inc. (NYSE: DOCS), the leading professional network for physicians, plummeted to a new 52-week low. On January 12, 2026, the stock touched $43.21, marking a dramatic retreat from its February 2025 peak of $85.21.

The company's third-quarter performance wasn't nearly as bad as the investor reaction to it might suggest.

Phreesia reports profitable Q3 with strong earnings beat and raises financial outlook following its strategic AccessOne acquisition.

Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase

Phreesia gains analyst support with price target hikes, though integration risks and modest guidance raise tempered investor enthusiasm.